Latest Conference Articles

The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.

Novel Hormone-Radiation Therapy Approaches

April 12th 2011

Radiation therapy (RT) used in combination with hormonal approaches continues to be a viable strategy for treating localized high-risk prostate cancer patients

PSA: To Screen or Not to Screen

April 12th 2011

Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella

Integrating New Hormonal Therapies in Advanced Disease

April 11th 2011

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Novel vaccine approaches: Prospects for PROSTVAC®-VF are bright

April 11th 2011

As research into novel vaccine approaches for treating advanced prostate cancer continues...

The Overtreatment of Prostate Cancer

April 11th 2011

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

Breast Reconstruction Trainee Assessment

March 18th 2011

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Osman on Designing the Program for the MBCC

March 16th 2011

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Dr. Fazel on Trends in Surgical Training

March 14th 2011

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Need for Survivorship Plans Emphasized

March 14th 2011

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative Therapy Offers Value to Patients

March 14th 2011

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

Framework for Evaluating Trial Results Detailed

March 14th 2011

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Genomic Profiles as Routine Care Are a Hot Topic

March 14th 2011

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized Treatment With Adjuvant Chemotherapy Shows Marginal Progress

March 14th 2011

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive

A Call for Change in Treating DCIS

March 11th 2011

It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ

Phase II Sorafenib Study Yields Positive Results

March 11th 2011

The addition of sorafenib to capecitabine as a first-line therapy for patients with advanced breast cancer

Dr. Osman on Detecting Malignant Breast Cancer

March 10th 2011

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

Malpractice Claims Target Breast Cancer Specialists

March 10th 2011

The climate for medical malpractice litigation in breast cancer treatment seems to be worsening

Diet and Lifestyle Are Factors in Breast Pain

March 10th 2011

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.